Cargando…

The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site

The HIV-1 envelope glycoproteins (Env) undergo conformational changes upon interaction of the gp120 exterior glycoprotein with the CD4 receptor. The gp120 inner domain topological layers facilitate the transition of Env to the CD4-bound conformation. CD4 engages gp120 by introducing its phenylalanin...

Descripción completa

Detalles Bibliográficos
Autores principales: Prévost, Jérémie, Tolbert, William D., Medjahed, Halima, Sherburn, Rebekah T., Madani, Navid, Zoubchenok, Daria, Gendron-Lepage, Gabrielle, Gaffney, Althea E., Grenier, Melissa C., Kirk, Sharon, Vergara, Natasha, Han, Changze, Mann, Brendan T., Chénine, Agnès L., Ahmed, Adel, Chaiken, Irwin, Kirchhoff, Frank, Hahn, Beatrice H., Haim, Hillel, Abrams, Cameron F., Smith, Amos B., Sodroski, Joseph, Pazgier, Marzena, Finzi, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251204/
https://www.ncbi.nlm.nih.gov/pubmed/32457241
http://dx.doi.org/10.1128/mBio.00280-20
Descripción
Sumario:The HIV-1 envelope glycoproteins (Env) undergo conformational changes upon interaction of the gp120 exterior glycoprotein with the CD4 receptor. The gp120 inner domain topological layers facilitate the transition of Env to the CD4-bound conformation. CD4 engages gp120 by introducing its phenylalanine 43 (Phe43) in a cavity (“the Phe43 cavity”) located at the interface between the inner and outer gp120 domains. Small CD4-mimetic compounds (CD4mc) can bind within the Phe43 cavity and trigger conformational changes similar to those induced by CD4. Crystal structures of CD4mc in complex with a modified CRF01_AE gp120 core revealed the importance of these gp120 inner domain layers in stabilizing the Phe43 cavity and shaping the CD4 binding site. Our studies reveal a complex interplay between the gp120 inner domain and the Phe43 cavity and generate useful information for the development of more-potent CD4mc.